-
Je něco špatně v tomto záznamu ?
Clinical and economic consequences of pancreatic fistula after elective pancreatic resection
F. Čečka, B. Jon, Z. Šubrt, A. Ferko,
Jazyk angličtina Země Singapur
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NS9998
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
Free Medical Journals
od 2002
Freely Accessible Science Journals
od 2002
- MeSH
- ambulantní péče ekonomika MeSH
- časové faktory MeSH
- délka pobytu ekonomika MeSH
- elektivní chirurgické výkony MeSH
- lidé středního věku MeSH
- lidé MeSH
- náklady a analýza nákladů MeSH
- nemocnice - náklady * MeSH
- pankreatektomie škodlivé účinky ekonomika MeSH
- pankreatická píštěl diagnóza ekonomika etiologie terapie MeSH
- senioři MeSH
- stupeň závažnosti nemoci MeSH
- výsledek terapie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: Postoperative pancreatic fistula is the main cause of morbidity after pancreatic resection. This study aimed to quantify the clinical and economic consequences of pancreatic fistula in a medium-volume pancreatic surgery center. METHODS: Hospital records from patients who had undergone elective pancreatic resection in our department were identified. Pancreatic fistula was defined according to the International Study Group on Pancreatic Fistula (ISGPF). The consequences of pancreatic fistula were determined by treatment cost, hospital stay, and out-patient follow-up until the pancreatic fistula was completely healed. All costs of the treatment are calculated in Euros. The cost increase index was calculated for pancreatic fistula of grades A, B, and C as multiples of the total cost for the no fistula group. RESULTS: In 54 months, 102 patients underwent elective pancreatic resections. Forty patients (39.2%) developed pancreatic fistula, and 54 patients (52.9%) had one or more complications. The median length of hospital stay for the no fistula, grades A, B, and C fistula groups was 12.5, 14, 20, and 59 days, respectively. The hospital stay of patients with fistula of grades B and C was significantly longer than that of patients with no fistula (P<0.001). The median total cost of the treatment was 4952, 4679, 8239, and 30 820 Euros in the no fistula, grades A, B, and C fistula groups, respectively. CONCLUSIONS: The grading recommended by the ISGPF is useful for comparing the clinical severity of fistula and for analyzing the clinical and economic consequences of pancreatic fistula. Pancreatic fistula prolongs the hospital stay and increases the cost of treatment in proportion to the severity of the fistula.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14063914
- 003
- CZ-PrNML
- 005
- 20140813111418.0
- 007
- ta
- 008
- 140704s2013 si f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/s1499-3872(13)60084-3 $2 doi
- 035 __
- $a (PubMed)24103285
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a si
- 100 1_
- $a Čečka, Filip $u Department of Surgery, Faculty of Medicine and University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. filip.cecka@seznam.cz.
- 245 10
- $a Clinical and economic consequences of pancreatic fistula after elective pancreatic resection / $c F. Čečka, B. Jon, Z. Šubrt, A. Ferko,
- 520 9_
- $a BACKGROUND: Postoperative pancreatic fistula is the main cause of morbidity after pancreatic resection. This study aimed to quantify the clinical and economic consequences of pancreatic fistula in a medium-volume pancreatic surgery center. METHODS: Hospital records from patients who had undergone elective pancreatic resection in our department were identified. Pancreatic fistula was defined according to the International Study Group on Pancreatic Fistula (ISGPF). The consequences of pancreatic fistula were determined by treatment cost, hospital stay, and out-patient follow-up until the pancreatic fistula was completely healed. All costs of the treatment are calculated in Euros. The cost increase index was calculated for pancreatic fistula of grades A, B, and C as multiples of the total cost for the no fistula group. RESULTS: In 54 months, 102 patients underwent elective pancreatic resections. Forty patients (39.2%) developed pancreatic fistula, and 54 patients (52.9%) had one or more complications. The median length of hospital stay for the no fistula, grades A, B, and C fistula groups was 12.5, 14, 20, and 59 days, respectively. The hospital stay of patients with fistula of grades B and C was significantly longer than that of patients with no fistula (P<0.001). The median total cost of the treatment was 4952, 4679, 8239, and 30 820 Euros in the no fistula, grades A, B, and C fistula groups, respectively. CONCLUSIONS: The grading recommended by the ISGPF is useful for comparing the clinical severity of fistula and for analyzing the clinical and economic consequences of pancreatic fistula. Pancreatic fistula prolongs the hospital stay and increases the cost of treatment in proportion to the severity of the fistula.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a ambulantní péče $x ekonomika $7 D000553
- 650 _2
- $a náklady a analýza nákladů $7 D003365
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a nemocnice - náklady $7 D017721
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a délka pobytu $x ekonomika $7 D007902
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a pankreatektomie $x škodlivé účinky $x ekonomika $7 D010180
- 650 _2
- $a pankreatická píštěl $x diagnóza $x ekonomika $x etiologie $x terapie $7 D010185
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 650 _2
- $a elektivní chirurgické výkony $7 D017558
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Jon, Bohumil
- 700 1_
- $a Šubrt, Zdeněk
- 700 1_
- $a Ferko, Alexander
- 773 0_
- $w MED00175712 $t Hepatobiliary & pancreatic diseases international : HBPD INT $x 1499-3872 $g Roč. 12, č. 5 (2013), s. 533-9
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24103285 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20140704 $b ABA008
- 991 __
- $a 20140813111746 $b ABA008
- 999 __
- $a ok $b bmc $g 1031398 $s 862646
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 12 $c 5 $d 533-9 $i 1499-3872 $m Hepatobiliary & pancreatic diseases international $n Hepatobiliary Pancreat Dis Int $x MED00175712
- GRA __
- $a NS9998 $p MZ0
- LZP __
- $a Pubmed-20140704